Browse by all authors Browse By Author Name - Wanstall,+J.+C.

Browse Results (22 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Awabdy, D., Bryan-Lluka, L. J. and Wanstall, J. C. (2001). 5-hydroxytryptamine and platelet function in hypoxic pulmonary hypertensive rats: Studies on uptake and aggregation. In: W. C. Hodgson and R. E. Loiacono, Proceedings of Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. ASCEPT Annual Scientific Meeting, University of Otago, Dunedin, New Zealand, (63-63). 3-5 December, 2001. 45  
Triggle, C. R., Lovren, F. and Wanstall, J. C. (2000). A comparasion of nitric oxide (NO) and NO donor-mediated relaxation of aorta from eNos -/-, eNOS +/+ and quackenbush mice. In: R. E. Widdop and C. G. Sobey, Proceedings of Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). Joint Meeting of ASCEPT and the British Pharmacological Society, University of Melbourne, Monash Unim RMIT Uni, (137-137). 26 - 28 April 2000. 62  
Thomas, B. J. and Wanstall, J. C. (2003) Alterations in pulmonary vascular function in rats exposed to intermittent hypoxia. European Journal of Pharmacology, 477 2: 153-161. doi:10.1016/j.ejphar.2003.08.015 37   25 Cited 25 times in Scopus25 0
Jeffery, T. and Wanstall, J. C. (1999). An agiotensin converting enzyme (ACE) inhibitor, perindopril, in pulmonary hypertensive rats: Contrasting effects on pulmonary vascular function and structure. In: J. F. Giudicelli, Fundamental and Clinical Pharmacology. 2nd European Congress of Pharmacology, Budapest, (156). 3 - 7 July,1999. 51  
Wanstall, J. C., Gambino, A., Jeffery, T. K., Bellomo, D., Cahill, M. M., Hayward, N. and Kay, G. F. (2001). A study on endothelium-dependent vasorelaxation and hypoxic pulmonary vascular remodelling in vascular endothelial growth factor-B deficient mice. In: W. C. Hodgson and R. E. Loiacono, Proceedings of the Australian Society of Clinical & Experimental Pharmacologists & Toxicologists. ASCEPT Annual Scientific Meeting, University of Otago, Dunedin, New Zealand, (34-34). 3-5 December 2001. 44  
Jeffery, T. and Wanstall, J. C. (1999). A study on perindopril (Angiotensin converting enzyme inhibitor) in hypoxic pulmonary hypertensive rats. In: J. Kunes, Pulmonary Circulation VII - Physiological Research. International Symposium - Pulmonary Circulation VII, Prague, Czech Republic, (54). June, 1999. 23  
Homer, K. and Wanstall, J. C. (1999). Characterisation of cGMP-Independent pulmonary vasorelaxation by nitric oxide donors. In: W. C. Hodgson and R. E. Loiacono, Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Sydney, (54). 4 - 8 December, 1999. 26  
Homer, K. L. and Wanstall, J. C. (2001). Characterisation of the inhibition by MAHMA NONOate (nitric oxide donor drug) of rat platelet aggregation. In: Proceedings of the Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists. Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting, Dunedin, New Zealand, (43-43). 3-5 December, 2001. 39  
Jeffery, T. and Wanstall, J. C. (1999). Comparative effects of a Ca2+-entry blocker and an angiotensin converting enzyme inhibitor in hypoxic pulmonary hypertensive rats. In: W.C. Hodgson and R.E. Loiacono, Proceedings of Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Sydney, (54). 4 - 8 December, 1999. 20  
Lovren, F., Wanstall, J. C. and Triggle, C. R. (2001). Effects of ODQ, NO scavengers and redox compounds on NO, NO- and NO+ induced relaxations in mouse aorta. In: S. Karim, S. Katz, J. McLarnon, J. McNeil, C. Pang and M. Walker, Proceedings of Pharmacology Vancouver 2001. Pharmacology Vancouver 2001, Vancouver, BC, Canada/Hyatt Regency, (129-129). 25-29 March 2001. 27  
Paczkowski, F. A., Wanstall, J. C. and Lluka, L.J. (2004). How do nitric oxide donors regulate the function of transporters for serotonin and noradrenaline?. In: Warwick P. Anderson, Abstracts of the 8th World Congress on Clinical and Experimental Pharmacology & Therapeutics. 8th World Congress on Clinical Pharmacology & Therapeutics, Brisbane, Australia, (A190-A190). 1-6 August 2004. 46  
Homer, K., Fiore, S. A. and Wanstall, J. C. (1999) Inhibition by 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one (ODQ) of responses to nitric oxide-donors in rat pulmonary artery: influence of the mechanism of nitric oxide generation. Journal of Pharmacy and Pharmacology, 51 2: 135-139. doi:10.1211/0022357991772240 34   29 0
Homer, K. and Wanstall, J. C. (2000). Inhibition by mahma nonoate (Nitric Oxide Donor) of rat platelet aggregation: Comparison with pulmonary vasorelaxation. In: W. C. Hodgson and R. E. Loiacono, Proceedings of ASCEPT. Joint Meeting of ASCEPT and the British Pharmacological Society, Monash University, Melbourne, (132-132). 3 - 6 December 2000. 27  
Homer, K. L. and Wanstall, J. C. (2002) Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate. British Journal of Pharmacology, 137 7: 1071-1081. doi:10.1038/sj.bjp.0704971 60   29 Cited 32 times in Scopus32 0
Jeffery, T. K. and Wanstall, J. C. (1999) Perindopril, an angiotensin converting enzyme inhibitor, in pulmonary hypertensive rats: comparative effects on pulmonary vascular structure and function. British Journal of Pharmacology, 128 7: 1407-1418. doi:10.1038/sj.bjp.0702923 39   23 Cited 24 times in Scopus24 0
Wanstall, J. C., Jeffery, T. and Gambino, A. (2000). Protease-activated receptor (PAR)-mediated responses in pulmonary arteries from normotensive and pulmonary hypertensive rats. In: R. E. Widdop and C. G. Sobey, Proceedings of Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). Joint Meeting of ASCEPT & the British Pharmacological Society, Uni of Melbourne, Monash Uni, RMIT Uni, (36-36). 26 - 28 April 2000. 18  
Jeffery, T.K. and Wanstall, J.C. (2001) Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacology & Therapeutics, 92 1: 1-20. doi:10.1016/S0163-7258(01)00157-7 50   166 Cited 188 times in Scopus188 0
Tsui, D. and Wanstall, J. C. (2001). S-nitrosocaptopril: Effects on pulmonary artery and platelets in normal rats and pulmonary artery pressure in pulmonary hypertensive rats. In: W.C. Hodgson and R.E. Loiacono, Proceedings of the Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists. ASCEPT Annual Scientific Meeting, University of Otago, Dunedin, New Zealand, (63-63). 3-5 December 2001. 38  
Tsui, D. Y. Y., Gambino, A. and Wanstall, J. C. (2003) S-Nitrosocaptopril: In vitro characterization of pulmonary vascular effects in rats. British Journal of Pharmacology, 138 5: 855-864. doi:10.1038/sj.bjp.0705128 44   11 Cited 15 times in Scopus15 0
Jones, R. D., Wanstall, J. C., Gambino, A. and Morice, A. H. (1999) The effect of the endothelin ETA receptor atagonist CI-1020 on hypoxic pulmonary vasconstriction. European Journal of Pharmacology, 374 3: 367-375. doi:10.1016/S0014-2999(99)00300-3 55   8 Cited 8 times in Scopus8 0
Wanstall, J. C., Gambino, A., Jeffery, T. K., Cahill, M. M., Bellomo, D., Hayward, N. and Kay, G.F. (2001). Vascular endothelial growth factor-B deficient mice exhibit normal endothelium-dependent vasorelaxation but subnormal response to chronic hypoxia. In: British Pharmacological Society, British Journal of Pharmacology: Proceedings of the British Pharmacological Society Meeting. British Pharmacological Society Meeting, University College Dublin, Ireland, (27p-27p). 3-5 July 2001. 28  
Wanstall, J. C., Gambino, A., Jeffery, T. K., Cahill, M. M., Bellomo, D., Hayward, N. K. and Kay, G. F. (2002) Vascular endothelial growth factor-B-deficient mice show impaired development of hypoxic pulmonary hypertension. Cardiovascular Research, 55 2: 361-368. doi:10.1016/S0008-6363(02)00440-6 33   31 Cited 34 times in Scopus34 0